Free Trial
→ Washington prepares for war (From Porter & Company) (Ad)tc pixel Free SLN Stock Alerts

Silence Therapeutics (SLN) SEC Filings & 10K Form

Silence Therapeutics logo
$5.30 +0.29 (+5.79%)
Closing price 03:59 PM Eastern
Extended Trading
$5.30 0.00 (-0.09%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Silence Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
5:30 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
7:04 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2025
6:35 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2025
7:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
7:43 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/23/2025
1:22 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2025
1:58 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2025
7:36 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2025
11:31 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2025
6:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2025
9:24 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
06/25/2025
7:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
5:46 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
7:06 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2025
10:21 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
7:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:49 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:12 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/20/2025
3:14 PM		MCINERNEY TIMOTHY (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
5:05 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form DEF 14A
05/16/2025
5:07 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form ARS
05/15/2025
8:02 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G/A
05/08/2025
9:18 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
05/08/2025
7:10 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2025
7:35 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:08 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2025
7:03 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
7:06 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form PRE 14A
05/02/2025
9:28 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:13 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
5:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2025
8:28 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
04/24/2025
6:16 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
9:35 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
1:17 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
6:50 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:47 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
9:50 AM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
03/06/2025
10:03 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
3:30 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
Trump’s betrayal exposed (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
02/27/2025
3:13 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
9:59 AM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:03 PM		Redmile Group, LLC (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G
02/11/2025
5:41 PM		Lombard Odier Asset Management Corp (0001491719) (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13G/A
01/02/2025
3:32 PM		HELLUMS RHONDA LYNETTE (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:34 PM		Davidson Michael H. (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:36 PM		Ede-Golightly James (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:38 PM		Ross Iain (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:39 PM		Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
TOOMAN CRAIG A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
3:43 PM		Griffiths Richard Ian (Reporting)
Silence Therapeutics plc (Issuer)
Silence Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2025
7:00 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2024
4:32 PM		Griffiths Richard Ian (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SCHEDULE 13D/A
12/09/2024
7:12 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
3:54 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
8:44 AM		Deep Track Capital, LP (Filed by)
Silence Therapeutics plc (Subject)
Silence Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:24 AM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:20 PM		Silence Therapeutics plc (Filer)
Silence Therapeutics (Filer)
Form F-3ASR
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLN) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Did you spot this in the Oval Office last week?
When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...
InvestorPlace | Sponsoredtc pixel
Trump’s national nightmare is here
The headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...
Porter & Company | Sponsoredtc pixel
Wall Street Legend Names #1 ‘Hidden’ AI Stock
50-year Wall Street legend says to forget NVDA. For the biggest potential gains, it's time to move your money ...
Chaikin Analytics | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
The man running the U.S. dollar… is hoarding gold
When the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...
Golden Portfolio | Sponsoredtc pixel
2013 Bitcoin miner reveals his trading system (free)
While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...
Crypto Swap Profits | Sponsoredtc pixel
“Shadow Group” in Washington, DC Could Crash Market
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel